| 作者: | Tong-Yun Wang # , Yue Sun #, Feng Cong , Yan-Dong Tang |
| 刊物名称: | Front Immunol |
| DOI: | 10.3389/fimmu.2026.1981961 |
| 发布时间: | 2026-11-16 |
| 摘要: | Review Cold tumors are poorly recognized by host immunity. Tumor tagging strategies-neoantigen, xenogeneic, and viral antigen tagging-endow tumor cells with identifiable antigens via engineered probiotics, oncolytic viruses, and mRNA delivery. These tactics yield compelling preclinical and clinical results, emerging as a novel promising strategy for cancer immunotherapy. Keywords: cancer immunotherapy; cold tumors; immune recognition; mRNA vaccines; oncolytic viruses; tumor tagging. |